Table 1.

Patient Baseline Demographics and Disease Characteristics

Characteristic	Cohort (n=12)
Age, years, median (range)	65.5 (55-78)
Race, n (%)
White	7 (58.3)
Black	4 (33.3)
Other	1 (8.3)
Gleason Sum, n (%)
7	1 (8.3)
8	3 (25.0)
9	7 (58.3)
10	1 (8.3)
Clinical T Stage, n (%)
T1c	3 (25.0)
T2b	5 (41.7)
T2c	3 (25.0)
T3	1 (8.3)
N Stage, n (%)
N0	7 (58.3)
N1	5 (41.7)
M Stage, n (%)
M1a	1 (8.3)
M1b	11 (91.7)
Number of Metastases
1	3 (25.0)
2-3	8 (66.7)
4-5	1 (8.3)
RECIST measurable disease
Yes	3 (25.0)
No	9 (75.0)
PSA, ng/mL, median (range)	43.3 (2.7-394.0)
Alkaline Phosphatase U/L, median (range)	78.5 (50-187)
Follow-Up, weeks, median (range)	136.1 (78.6-170.9)